GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Comp En De Mn Cemig Ads (CIG) [hlAlert]

Rating:
Buy CIG
down 74.59 %

Comp En De Mn Cemig Ads (CIG) rated Buy by Standpoint Research

Posted on: Monday,  May 20, 2013  10:25 AM ET by Standpoint Research

Standpoint Research rated Buy Comp En De Mn Cemig Ads (NYSE: CIG) on 05/20/2013, when the stock price was $8.94.
Since then, Comp En De Mn Cemig Ads has lost 74.60% as of 09/08/2015's recent price of $2.27.
If you would have followed this Standpoint Research's recommendation on CIG, you would have lost 74.59% of your investment in 841 days.

Companhia Energetica de Minas Gerais (CEMIG) is a Brazil-based company involved in the energy sector. It is mainly engaged in the generation, transmission and distribution of electric energy for industrial, residential, commercial and rural consumption. The Company is also engaged in other businesses, such as natural gas distribution in Minas Gerais through Companhia de Gas de Minas Gerais (Gasmig); telecommunications through Empresa de Infovias SA, which provides fiber-optics and coaxial cable network installed along its transmission and distribution lines; national and international consulting business through Efficientia SA, which provides energy solutions for the implementation and management of systems for electricity sector, among others. In 2009, the Company is due to start operating abroad, through its subsidiary Transchile Charrua Transmision SA, in the Chilean unit LT Charrua ? Nueva Temuco.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/20/2013 10:25 AM Buy
None
8.94
as of 12/13/2013
1 Week down  -7.71 %
1 Month down  -6.69 %
3 Months down  -7.26 %
1 YTD down  -29.46 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/30/2012 3:25 PM Buy
None
9.76
1/23/2012 12:25 PM Hold
None
12.59 14.08
9/6/2011 11:25 AM Buy
None
11.45 13.44
3/30/2011 11:25 AM Hold
None
12.28
2/5/2010 2:25 PM Buy
None
10.18
12/3/2009 2:25 PM Hold
None
12.46
12/15/2008 8:25 AM Buy
None
9.15 16.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy